Factors Associated with Opioid-Related Fatal and Non-fatal Overdose

Similar documents
2017 Optum, Inc. All rights reserved BH1124_112017

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!

The Role of Prevention in Addressing Opioid Overdose

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Attachment 3. Efforts to Address the Opioid Epidemic in Clark County

Orange County Heroin Task Force: A targeted approach to improving outcomes

Influenza (Flu) Fact Sheet

Medication Guide ABSTRAL (AB-stral) CII (fentanyl) Sublingual tablets

US Public Health Service Clinical Practice Guidelines for PrEP

Medication Assisted Treatment for Opioid Use Disorder in Rural Colorado

Medicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Opioid Analgesics PA Request Provider Checklist

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Risk factors in health and disease

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

Completing the NPA online Patient Safety Incident Report form: 2016

Related Policies None

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

3903 Fair Ridge Drive, Suite 209, Fairfax, VA Harry Byrd Hwy, Suite 285, Ashburn, VA *How did you hear about our program?

Methadone Maintenance Treatment for Opioid Dependence

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

The data refer to persons aged between 15 and 54.

Top 10 Causes of Disability

THE DANISH HARM REDUCTION MODEL

Introduction. Forensic toxicology helps determine cause-and-effect relationships. Toxic or lethal effects from that exposure. between.

Supporting Psychosocial Health and Resilience in Liberia. Japanese Social Development Fund The World Bank 4 March, 2015

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

Significance of Chronic Kidney Disease in 2015

Original Policy Date 12:2013

Cardiac Rehabilitation Services

Solid Organ Transplant Benefits to Change for Texas Medicaid

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place

MINISTRY OF HEALTH INFORMATION BRIEFING NOTE

Young Hackney Substance Misuse Service

STRATEGIC PLAN APRIL 2018

The policy was formulated through consultation between members of staff, governors, parents and pupils.

S.K.J Construction Ltd Groundwork & Civil Engineering

FTD RESEARCH: The Value of Studies and Opportunities for Involvement

Prescribing Safely to Prevent Misuse & Diversion

Ill Health. Unit reference number: L/616/7295 Level: 3. Credit value: 3 Guided learning hours: 16. Unit summary

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Standard Statement Content Words Essential Questions Knowledge and/or Skill Topic Assessment A. Analyze factors that impact growth and development

CHAPTER 2. HEALTH SERVICES

State Health Improvement Plan Choosing Priorities, Creating a Plan. DHHS DPH - SHIP Priorities (Sept2016) 1

Cancer Association of South Africa (CANSA)

Advantage EAP Employee Assistance Program

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

PART III: CONSUMER INFORMATION

Obesity/Morbid Obesity/BMI

These are medical emergencies that can cause death. If possible, remove OTFC from the mouth.

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)

Flu Season Key Points ( )

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

EAST VALLEY DERMATOLOGY CENTER

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Psychological aspects of breast cancer. Dr Caroline Dancyger & Dr Esther Hansen

Annex III. Amendments to relevant sections of the Product Information

FIGHT DEMENTIA ACTION PLAN

MEDICATION GUIDE. (Interferon alfa-2b)

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

PATIENT INFORMATION. effective for the treatment of the flu in people with long-time (chronic) heart problems or breathing problems.

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.

/0515 Medication Guide Aripiprazole Tablets

Forensic Science: Fundamentals & Investigations, 2e Chapter 9. All rights Reserved Cengage/NGL/South-Western 2016

Frequently Asked Questions: IS RT-Q-PCR Testing

Meeting Minutes. III. New Business (Slide Presentation is embedded for reference) [slides 3-47] May 2011 DMRAB Presentation PUBLIC C

Creating and Linking Charge Objects

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

Evaluation of a Shared Decision Making Intervention between Patients and Providers to Improve Menopause Health Outcomes: Issue Brief

Preventing Suicide: Review of Safety Protocol for Suicidal Students. Maureen Cooper Jamie Anderson

Drug Class Review: Long-acting muscarinic antagonists (LAMAs) for treatment of chronic obstructive pulmonary disease (COPD)

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Osteoporosis Fast Facts

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for Sublingual or Buccal Administration (CIII)

BARNSLEY BUSINESS DELIVERY UNIT COMMUNITY SUBSTANCE MISUSE TEAM

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

Part 1 describes the reasoning and recommendations up to node 2 of the algorithm.

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

Commissioning Policy: South Warwickshire CCG (SWCCG)

Chronic Non Malignant Pain - Strong Opioid Prescribing Guideline and Educational Pack

Candida March, Ines Smyth, and Maitrayee Mukhopadhyay, 1999, A Guide to Gender-Analysis Frameworks, London: Oxfam Publishing.

A. Catalonia World Health Organization Demonstration Project

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV

Seeking and Appraising Evidence

of Communication and Interactions with Individuals who have Dementia

Sub-Topic: Massage for Depression, Anxiety, and Sleep Disorders Level 1 Knowledge: Attain and Comprehend Skills: Observe and Imitate

SURGICAL NOTE. Surgical Recommendations to Optimize Femoral/Iliac Artery Cannulation

Evaluation of Hunter & New England HealthPathways

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

OTHER AND UNSPECIFIED DISORDERS

Social Learning Theories

NUCYNTA ER (tapentadol extended-release tablets) Fact Sheet

CDC Influenza Division Key Points November 7, 2014

For our protection, we require verification that you have received this notice. Therefore, please sign below.

Transcription:

Factrs Assciated with Opiid-Related Fatal and Nn-fatal Overdse Understanding the factrs assciated with piid-related fatal and nn-fatal verdse and can help practitiners assess, plan fr, and select interventins t address them. Researchers have identified a variety f factrs that place individuals at increased risk fr piid verdse (and death in the event f an verdse). These can be rganized int the fllwing categries: Opiid Use and Misuse Ability t Prcess Opiids Chrnic Pain and Mental Health Opiid Access and Supply Opiid Knwledge and Perceptins Nn-fatal Overdse OPIOID USE AND MISUSE Bth medical and illicit use f piids can place individuals a risk f fatal and nn-fatal verdse. Risk factrs assciated with the medical use f prescriptin piids include: Prescriptins that are lng-term, r fr high dses r lng-acting piids Having cncurrent prescriptins (fr example, fr multiple piids r fr bth piids and benzdiazepines) Risk factrs assciated with the illicit use f any piids include: Nn-medical use f prescriptin piids Use f herin and ther nn-prescriptin piids Illicit use f piids in cmbinatin with ther cntrlled substances (similar t medical use) PAGE 1 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS283201200024I/HHSS28342002T. Fr training use nly. March 21, 2017 http://www.samhsa.gv/capt/ PAGE 1

Finally, use f piids alne (withut ther individuals arund t respnd) is assciated with increased risk f death in the event f an verdse. ABILITY TO PROCESS OPIOIDS An individual s ability t physically prcess an piid is influenced by several factrs that can increase ne s risk fr fatal r nn-fatal verdse: piid dependence, changes in piid tlerance, and cmprmised physical health. Opiid dependence, a physical adaptatin t piids that prduces withdrawal symptms when piid use stps, may lead t piid misuse r additin, which is assciated with increased verdse risk Risk factrs assciated with piid tlerance (the bdy s ability t prcess and experience the effects f a certain amunt f a substance) include: An increase in tlerance (needing mre f a drug in rder t experience the same effect) Decrease in tlerance with time away frm use (due t hspitalizatin, treatment, r incarceratin) Risk factrs assciated with physical health prblems include: A cmprmised immune system Pulmnary dysfunctin (including lung damage and disrders such as asthma, emphysema, r sleep apnea) Liver dysfunctin CHRONIC PAIN AND MENTAL HEALTH In additin t the physical health factrs that may influence an individual s ability t prcess piids, several ther physical and mental health issues as assciated with an increased risk fr piidrelated fatal and nn-fatal verdse. Chrnic pain, defined as pain that lasts lnger than 3 mnths r past the time an injury is expected t heal Mental health disrders, including depressin, anxiety, and/r substance use disrders Risk factrs assciated with adverse life experiences include: Having witnessed a family member verdse Financial struggles, including unemplyment Hmelessness PAGE 2 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS283201200024I/HHSS28342002T. Fr training use nly. March 21, 2017 http://www.samhsa.gv/capt/ PAGE 2

OPIOID ACCESS AND SUPPLY Factrs that increase the availability f prescriptin and nn-prescriptin piids such as piid prescribing practices, diversin f prescriptin piids, and changes in the lcal drug supply as assciated with increased risk fr fatal and nn-fatal verdse. Risk factrs assciated with piid prescribing practices include: Increases in piid dsage and/r duratin f use, and number f pills prescribed (that is, days supply) Increases in the number f piid prescriptins written The diversin f prescriptin piids r redirectin f cntrlled substances frm their lawful purpse t illicit use is assciated with increased risk fr piid-related verdse. Prescriptin drugs can be diverted thrugh peple such as: Friends r relatives Healthcare prviders Drug dealers Risk factrs assciated with changes in the lcal drug supply include: Increases in the availability and decreases in the cst f herin Increases in the purity f herin Increases in the number f street drugs, including herin, testing psitive fr fentanyl and ther ptent piids OPIOID KNOWLEDGE AND PERCEPTIONS An individual s lack f knwledge abut piids and risks assciated with their misuse, including verdse, and their perceptins twards these drugs can place them at increased risk fr verdse. Risk factrs assciated with piid knwledge and perceptins include: A lack f understanding r awareness f verdse risks (such as the risks assciated with using piids and ther substances cncurrently) A lw perceptin f the harms assciated with piids, specifically prescriptin piids NON-FATAL OVERDOSE Experiencing a nn-fatal piid verdse in the past increases peple s risk f suffering a fatal verdse in the future. PAGE 3 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS283201200024I/HHSS28342002T. Fr training use nly. March 21, 2017 http://www.samhsa.gv/capt/ PAGE 3

Risk factrs assciated with nn-fatal verdse include: The specific factrs that caused the initial verdse, including high-risk piid misuse. Any physical health prblems caused by the verdse itself, which may include damage t the brain, heart, liver, r kidneys. REFERENCES Baumblatt, J. A. G., Wiedeman, C., Dunn, J. R., Schaffner, W., Paulzzi, L. J., & Jnes, T. F. (2014). High-risk use by patients prescribed piids fr pain and its rle in verdse deaths. JAMA Internal Medicine, 174(5), 796-801. Betts, K. S., McIlwraith, F., Dietze, P., Whittaker, E., Burns, L., Cgger, S., & Alati, R. (2015). Can differences in the type, nature r amunt f plysubstance use explain the increased risk f nn-fatal verdse amng psychlgically distressed peple wh inject drugs? Drug and Alchl Dependence, 154, 76-84. Bhnert, A. S. B., Valenstein, M., Bair, M. J., Ganczy, D., McCarthy, J. F., Ilgen, M. A., & Blw, F. C. (2011). Assciatin Between Opiid Prescribing Patterns and Opiid Overdse-Related Deaths. JAMA, 305(13), 1315-1321. Bnar, E. E., & Bhnert, A. S. (2016). Perceived severity f and susceptibility t verdse amng injectin drug users: Relatinships with verdse histry. Substance Use & Misuse, 51(10), 1379-1383. Green, T. C., Black, R., Grimes Serran, J. M., Budman, S. H., & Butler, S. F. (2011). Typlgies f prescriptin piid use in a large sample f adults assessed fr substance abuse treatment. PLOS ONE, 6(11), e27244. Jhnsn, E. M., Lanier, W. A., Merrill, R. M., Crk, J., Prucznik, C. A., Rlfs, R. T., & Sauer, B. (2013). Unintentinal prescriptin piid-related verdse deaths: descriptin f decedents by next f kin r best cntact, Utah, 2008 2009. Jurnal f General Internal Medicine, 28(4), 522-529. Kinner, S. A., Milly, M. J., Wd, E., Qi, J., Zhang, R., & Kerr, T. (2012). Incidence and risk factrs fr nn-fatal verdse amng a chrt f recently incarcerated illicit drug users. Addictive Behavirs, 37(6), 691-696. Neira-León, M., Barri, G., Brav, M. J., Brugal, M. T., de la Fuente, L., Dming-Salvany, A., Pulid, J., Sants, S., & Prject Itinere Grup. (2011). Infrequent piid verdse risk reductin behaviurs amng yung adult herin users in cities with wide cverage f HIV preventin prgrammes. Internatinal Jurnal f Drug Plicy, 22(1), 16-25. Peirce, G. L., Smith, M. J., Abate, M. A., & Halversn, J. (2012). Dctr and pharmacy shpping fr cntrlled substances. Medical Care, 50(6), 494-500. Riley, E. D., Evans, J. L., Hahn, J. A., Bricen, A., Davidsn, P. J., Lum, P. J., & Page, K. (2016). A lngitudinal study f multiple drug use and verdse amng yung peple wh inject drugs. American Jurnal f Public Health, 106(5), 915-917. Siegler, A., Tuazn, E., Bradley O Brien, D., & Pane, D. (2014). Unintentinal piid verdse deaths in New Yrk City, 2005 2010: A place-based apprach t reduce risk. Internatinal Jurnal f Drug Plicy, 25(3), 569-574. Silva, K., Schrager, S. M., Kecjevic, A., & Lankenau, S. E. (2013). Factrs assciated with histry f nn-fatal verdse amng yung nnmedical users f prescriptin drugs. Drug and Alchl Dependence, 128(1-2), 104-110. PAGE 4 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS283201200024I/HHSS28342002T. Fr training use nly. March 21, 2017 http://www.samhsa.gv/capt/ PAGE 4

Yarbrugh, B. J., Stumb, S. P., Janff, S. L., Yarbrugh, M. T., McCarty, D., Chilcat, H. D., Cplan, P. M., & Green, C. A. (2016 ). Understanding piid verdse characteristics invlving prescriptin and illicit piids: A mixed methds analysis. Drug and Alchl Dependence, 167, 49-56. Yang, Z., Wilsey, B., Bhm, M., Weyrich, M., Ry, K., Ritley, D., Jnes, C., & Melnikw, J. (2015). Defining risk f prescriptin piid verdse: pharmacy shpping and verlapping prescriptins amng lng-term piid users in medicaid. The Jurnal f Pain, 16(5), 445-453. Zedler, B., Xie, L., Wang, L., Jyce, A., Vick, C., Karibury, F., Rajan, P., Baser, O., & Murrelle, L. (2014). Risk factrs fr serius prescriptin piid-related txicity r verdes amng Veterans Health Administratin patients. Pain Medicine, 15(11), 1911-1929. Zedler, B., Xie, L., Wang, L., Jyce, A., Vick, C., Brigham, J., Karibury, F., Baser, O., & Murrelle, L. (2015). Develpment f a risk index fr serius prescriptin piid-induced respiratry depressin r verdse in Veterans Health Administratin patients. Pain Medicine, 16(8), 1566-1579. PAGE 5 Develped under the Substance Abuse and Mental Health Services Administratin s Center fr the Applicatin f Preventin Technlgies task rder. Reference #HHSS283201200024I/HHSS28342002T. Fr training use nly. March 21, 2017 http://www.samhsa.gv/capt/ PAGE 5